Skip to main content

We've updated our Privacy Policy. Questions? Email us any time at privacy@ground.news

Published loading...Updated

Study Finds NICE Breast Cancer Referral Criteria Miss Most Future Cases in Under-50s

Researchers found family-history referral rules identified fewer than 5% of women who later developed breast cancer, while BOADICEA performed well.

  • On Tuesday, August 4, 2026, researchers published findings in the British Journal of Cancer showing NICE referral criteria miss up to 95% of women under 50 who develop breast cancer within a decade.
  • Current NICE guidelines rely solely on family history for GP referrals, yet 73% of women under 50 who develop breast cancer have no family history of the disease.
  • Using the BOADICEA risk assessment tool, experts identified eight times as many women at risk compared to NICE criteria, with 26.5% of women under 50 classed as above-population level risk.
  • NICE welcomed the findings but stated current evidence does not warrant guideline changes, while Professor Montserrat Garcia-Closas warned comprehensive assessment would place heavy burdens on NHS resources.
  • Dr. Simon Vincent, chief scientific officer at Breast Cancer Now, stated the research must be considered in future Family History guideline reviews, as public support exists for proactive risk assessment approaches.
Insights by Ground AI

15 Articles

Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/yearSubscribe

Bias Distribution

  • 42% of the sources lean Right
42% Right

Factuality Info Icon

To view factuality data please Upgrade to Premium

Ownership

Info Icon

To view ownership data please Upgrade to Vantage

The Independent broke the news in London, United Kingdom on Tuesday, August 4, 2026.
Too Big Arrow Icon
Sources are mostly out of (0)

Similar News Topics

News
Feed Dots Icon
For You
Search Icon
Search
Blindspot LogoBlindspotLocal